This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Jun;39(6):410-4.

doi: 10.1136/jmg.39.6.410.

What do women really want to know? Motives for attending familial breast cancer clinics

C J Van Asperen, S Van Dijk, M W Zoeteweij, D R M Timmermans, G H De Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, W Otten

PMID: 12070250
PMCID: PMC1735148
DOI: 10.1136/jmg.39.6.410

Comment

What do women really want to know? Motives for attending familial breast cancer clinics

C J Van Asperen et al. J Med Genet. 2002 Jun.

. 2002 Jun;39(6):410-4.

doi: 10.1136/jmg.39.6.410.

Authors

C J Van Asperen, S Van Dijk, M W Zoeteweij, D R M Timmermans, G H De Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, W Otten

PMID: 12070250
PMCID: PMC1735148
DOI: 10.1136/jmg.39.6.410

No abstract available

PubMed Disclaimer

Comment on

Why do women attend familial breast cancer clinics?
Brain K, Gray J, Norman P, Parsons E, Clarke A, Rogers C, Mansel R, Harper P. Brain K, et al. J Med Genet. 2000 Mar;37(3):197-202. doi: 10.1136/jmg.37.3.197. J Med Genet. 2000. PMID: 10699056 Free PMC article.

Similar articles

What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations.
Armstrong K, Stopfer J, Calzone K, Fitzgerald G, Coyne J, Weber B. Armstrong K, et al. Genet Test. 2002 Summer;6(2):115-8. doi: 10.1089/10906570260199366. Genet Test. 2002. PMID: 12215250
The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.
Sermijn E, Goelen G, Teugels E, Kaufman L, Bonduelle M, Neyns B, Poppe B, De Paepe A, De Grève J. Sermijn E, et al. J Med Genet. 2004 Mar;41(3):e23. doi: 10.1136/jmg.2003.011353. J Med Genet. 2004. PMID: 14985394 Free PMC article. No abstract available.
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, Sánchez-de-Abajo A, Caldés T, Blanco A, Graña B, Durán M, Velasco E, Chirivella I, Cardeñosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martínez E, Guillén C, Salazar R, San Román C, Antoniou AC, Urioste M, Benítez J. Milne RL, et al. Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436. Clin Cancer Res. 2008. PMID: 18451254
When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.
Speight B, Tischkowitz M. Speight B, et al. J Genet Couns. 2017 Dec;26(6):1173-1178. doi: 10.1007/s10897-017-0136-1. Epub 2017 Aug 5. J Genet Couns. 2017. PMID: 28780755 Free PMC article. Review.
"I do not want my baby to suffer as I did"; prenatal and preimplantation genetic diagnosis for BRCA1/2 mutations: a case report and genetic counseling considerations.
Dagan E, Gershoni-Baruch R, Kurolap A, Goldberg Y, Fried G. Dagan E, et al. Genet Test Mol Biomarkers. 2014 Jul;18(7):461-6. doi: 10.1089/gtmb.2013.0513. Epub 2014 Jun 10. Genet Test Mol Biomarkers. 2014. PMID: 24915046 Review.

See all similar articles

Cited by

Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.
Bellcross CA, Peipins LA, McCarty FA, Rodriguez JL, Hawkins NA, Hensley Alford S, Leadbetter S. Bellcross CA, et al. Genet Med. 2015 Jan;17(1):43-50. doi: 10.1038/gim.2014.68. Epub 2014 Jun 19. Genet Med. 2015. PMID: 24946155 Free PMC article.
What information do cancer genetic counselees prioritize?
Hayat Roshanai A, Lampic C, Ingvoldstad C, Askmalm MS, Bjorvatn C, Rosenquist R, Nordin K. Hayat Roshanai A, et al. J Genet Couns. 2012 Aug;21(4):510-26. doi: 10.1007/s10897-011-9409-2. Epub 2011 Oct 13. J Genet Couns. 2012. PMID: 21993709
Cancer genetic predisposition: information needs of patients irrespective of risk level.
Metcalfe A, Werrett J, Burgess L, Chapman C, Clifford C. Metcalfe A, et al. Fam Cancer. 2009;8(4):403-12. doi: 10.1007/s10689-009-9256-6. Epub 2009 Jun 11. Fam Cancer. 2009. PMID: 19517270
Experiences and interpretations of BRCA1/2 testing among women affected by breast or ovarian cancer who received a negative result.
Stafford L, Flehr A, Judd F, Lindeman GJ, Gibson P, Komiti A, Mann GB, Kentwell M. Stafford L, et al. J Community Genet. 2019 Oct;10(4):501-514. doi: 10.1007/s12687-019-00415-w. Epub 2019 Mar 27. J Community Genet. 2019. PMID: 30919324 Free PMC article.
Cancer genetic counseling: communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment.
Pieterse AH, van Dulmen AM, Beemer FA, Bensing JM, Ausems MG. Pieterse AH, et al. J Genet Couns. 2007 Feb;16(1):85-96. doi: 10.1007/s10897-006-9048-1. Epub 2007 Feb 13. J Genet Couns. 2007. PMID: 17295054 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information